Contribute
España
Italia
대한민국
日本
Français

Benzinga

Research
My Stocks
Tools
Free Benzinga Pro Trial
SPY
761.930.02%
QQQ
707.830.03%
BTC/USD
77264.100.1659%
DIA
527.670.02%
GLD
396.500.06%
TLT
81.830.05%

Traws Pharma Inc

TRAWNASDAQ
Trade with Public
Trade with Public
$0.5900
-0.002-0.34%
At close: Sep 1, 5:00 PM EST
$0.5902
0.00020.03%
After Hours: 7:58 PM EST
OverviewNewsEarnings ForecastPrice TargetsFinancialsSentimentOwnershipCompareStock Report

Traws Pharma Analyst Price Targets

Wall Street analyst price targets and consensus rating for Traws Pharma (TRAW).

Price Target Range — 3 Quarters

Analyst Consensus — 2 Analysts

2Hold
Consensus RatingNeutral# Analysts2Avg. Consensus PT$1Upside to Avg. PT+69.4%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →
DateFirmAnalystActionRating ChangePrice Target
Aug 18, 2026HC Wainwright & Co.Brandon FolkesMaintainedNeutral$1
Jun 18, 2026HC Wainwright & Co.Brandon FolkesDowngradeBuy→Neutral$1
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
HC Wainwright & Co. Reiterates Neutral on Traws Pharma, Maintains $1 Price Target

HC Wainwright & Co. analyst Brandon Folkes reiterates Traws Pharma (NASDAQ:TRAW) with a Neutral and maintains $1 price target.
Benzinga Newsdesk

This Intuit Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Thursday

Wall Street analysts updated ratings for CURB, INTU, ENGN. See their outlooks and targets at Benzinga's analyst ratings page.
Avi Kapoor

PRO
HC Wainwright & Co. Downgrades Traws Pharma to Neutral, Announces $1 Price Target

HC Wainwright & Co. analyst Brandon Folkes downgrades Traws Pharma (NASDAQ:TRAW) from Buy to Neutral and announces $1 price target.
Benzinga Newsdesk

PRO
Ladenburg Thalmann Downgrades Traws Pharma to Neutral

Ladenburg Thalmann analyst Kevin DeGeeter downgrades Traws Pharma (NASDAQ:TRAW) from Buy to Neutral.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Traws Pharma, Maintains $8 Price Target

HC Wainwright & Co. analyst Brandon Folkes reiterates Traws Pharma (NASDAQ:TRAW) with a Buy and maintains $8 price target.
Benzinga Newsdesk

This Linde Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

Avi Kapoor

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved